Weaver C. Barksdale & Associates’s Acadia Healthcare ACHC Stock Holding History

Weaver C. Barksdale & Associates’s Portfolio ACHC Stock Details ACHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$16K	Buy	493 +184	+60%	+$6.38K	0.02%	188
2017 Q3	$15K	Sell	309 -20	-6%	-$975	0.02%	192
2017 Q2	$16K	Buy	+329	New	+$14.6K	0.02%	184
2016 Q1	–	Sell	-38,276	Closed	-$2.39M	–	547
2015 Q4	$2.39M	Hold	38,276	–	–	1.87%	24
2015 Q3	$2.54M	Buy	38,276 +2,328	+6%	+$179K	2.04%	12
2015 Q2	$2.82M	Buy	+35,948	New	+$2.59M	2.07%	13

Other funds holding ACHC

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

PCP

P2 Capital Partners New York $210M AUM 1.23% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Weaver C. Barksdale & Associates's ACHC Position: Q4 2017 in Review

Weaver C. Barksdale & Associates increased its Acadia Healthcare (ACHC) stake by 60% in Q4 2017, buying an estimated $6.38K and bringing the position to 493 shares worth $16K. The position accounts for 0.02% of the portfolio, ranked #188.

Weaver C. Barksdale & Associates first reported a position in ACHC in Q2 2015 and has held it in 6 quarters since. The position peaked at $2.82M in Q2 2015. 262 funds tracked by Wall St. Rank hold ACHC as of Q4 2017.

Weaver C. Barksdale & Associates held 493 shares of Acadia Healthcare worth $16K as of Q4 2017.
Weaver C. Barksdale & Associates bought 184 Acadia Healthcare shares in Q4 2017, an estimated $6.38K.
Acadia Healthcare made up 0.02% of Weaver C. Barksdale & Associates's portfolio in Q4 2017, its #188 holding.
Weaver C. Barksdale & Associates first reported a position in Acadia Healthcare in Q2 2015 and has held it in 6 quarters since.
Weaver C. Barksdale & Associates's Acadia Healthcare position peaked at $2.82M in Q2 2015.
262 funds tracked by Wall St. Rank held Acadia Healthcare as of Q4 2017.

Based on Weaver C. Barksdale & Associates's 13F filing for Q4 2017, filed 10 Jan 2018.